Sökning: WFRF:(Rye David) > (2022) > Increased soluble u...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05686naa a2200781 4500 | |
001 | oai:lup.lub.lu.se:d5f3a83a-3afc-47a9-afad-50412b1ec4ec | |
003 | SwePub | |
008 | 230113s2022 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/d5f3a83a-3afc-47a9-afad-50412b1ec4ec2 URI |
024 | 7 | a https://doi.org/10.1172/JCI1587882 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Hindy, Georgeu Lund University,Lunds universitet,Kardiovaskulär forskning - hypertoni,Forskargrupper vid Lunds universitet,Cardiovascular Research - Hypertension,Lund University Research Groups,Broad Institute,Qatar University4 aut0 (Swepub:lu)med-ghu |
245 | 1 0 | a Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis |
264 | 1 | c 2022 |
520 | a People with kidney disease are disproportionately affected by atherosclerosis for unclear reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived mediator of kidney disease, levels of which are strongly associated with cardiovascular outcomes. We assessed suPAR’s pathogenic involvement in atherosclerosis using epidemiologic, genetic, and experimental approaches. We found serum suPAR levels to be predictive of coronary artery calcification and cardiovascular events in 5,406 participants without known coronary disease. In a genome-wide association meta-analysis including over 25,000 individuals, we identified a missense variant in the plasminogen activator, urokinase receptor (PLAUR) gene (rs4760), confirmed experimentally to lead to higher suPAR levels. Mendelian randomization analysis in the UK Biobank using rs4760 indicated a causal association between genetically predicted suPAR levels and atherosclerotic phenotypes. In an experimental model of atherosclerosis, proprotein convertase subtilisin/kexin–9 (Pcsk9) transfection in mice overexpressing suPAR (suPARTg) led to substantially increased atherosclerotic plaques with necrotic cores and macrophage infiltration compared with those in WT mice, despite similar cholesterol levels. Prior to induction of atherosclerosis, aortas of suPARTg mice excreted higher levels of CCL2 and had higher monocyte counts compared with WT aortas. Aortic and circulating suPARTg monocytes exhibited a proinflammatory profile and enhanced chemotaxis. These findings characterize suPAR as a pathogenic factor for atherosclerosis acting at least partially through modulation of monocyte function. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
700 | 1 | a Tyrrell, Daniel J.u University of Michigan4 aut |
700 | 1 | a Vasbinder, Alexiu University of Michigan4 aut |
700 | 1 | a Wei, Changliu Rush University Medical Center Chicago4 aut |
700 | 1 | a Presswalla, Ferielu University of Michigan4 aut |
700 | 1 | a Wang, Huiu University of Michigan4 aut |
700 | 1 | a Blakely, Pennelopeu University of Michigan4 aut |
700 | 1 | a Ozel, Ayse Bilgeu University of Michigan4 aut |
700 | 1 | a Graham, Sarahu University of Michigan4 aut |
700 | 1 | a Holton, Grace H.u University of Michigan4 aut |
700 | 1 | a Dowsett, Josephu Copenhagen University Hospital4 aut |
700 | 1 | a Fahed, Akl C.4 aut |
700 | 1 | a Amadi, Kingsley-michael4 aut |
700 | 1 | a Erne, Grace K.4 aut |
700 | 1 | a Tekmulla, Annika4 aut |
700 | 1 | a Ismail, Anis4 aut |
700 | 1 | a Launius, Christopher4 aut |
700 | 1 | a Sotoodehnia, Nona4 aut |
700 | 1 | a Pankow, James S.4 aut |
700 | 1 | a Thørner, Lise Wegner4 aut |
700 | 1 | a Erikstrup, Christian4 aut |
700 | 1 | a Pedersen, Ole Birger4 aut |
700 | 1 | a Banasik, Karina4 aut |
700 | 1 | a Brunak, Søren4 aut |
700 | 1 | a Ullum, Henrik4 aut |
700 | 1 | a Eugen-Olsen, Jesper4 aut |
700 | 1 | a Ostrowski, Sisse Rye4 aut |
700 | 1 | a Haas, Mary E.4 aut |
700 | 1 | a Nielsen, Jonas B.4 aut |
700 | 1 | a Lotta, Luca A.4 aut |
700 | 1 | a Engström, Gunnaru Lund University,Lunds universitet,Kardiovaskulär forskning - epidemiologi,Forskargrupper vid Lunds universitet,Cardiovascular Research - Epidemiology,Lund University Research Groups4 aut0 (Swepub:lu)smi-gen |
700 | 1 | a Melander, Olleu Lund University,Lunds universitet,Kardiovaskulär forskning - hypertoni,Forskargrupper vid Lunds universitet,Cardiovascular Research - Hypertension,Lund University Research Groups4 aut0 (Swepub:lu)endo-ome |
700 | 1 | a Orho-Melander, Marjuu Lund University,Lunds universitet,Diabetes - kardiovaskulär sjukdom,Forskargrupper vid Lunds universitet,Diabetes - Cardiovascular Disease,Lund University Research Groups4 aut0 (Swepub:lu)endo-mor |
700 | 1 | a Zhao, Lili4 aut |
700 | 1 | a Murthy, Venkatesh L.4 aut |
700 | 1 | a Pinsky, David J.4 aut |
700 | 1 | a Willer, Cristen J.4 aut |
700 | 1 | a Heckbert, Susan R.4 aut |
700 | 1 | a Reiser, Jochen4 aut |
700 | 1 | a Goldstein, Daniel R.4 aut |
700 | 1 | a Desch, Karl C.4 aut |
700 | 1 | a Hayek, Salim S.4 aut |
710 | 2 | a Kardiovaskulär forskning - hypertonib Forskargrupper vid Lunds universitet4 org |
773 | 0 | t Journal of Clinical Investigationg 132:24, s. 1-14q 132:24<1-14x 0021-9738 |
856 | 4 | u https://www.jci.org/articles/view/158788y FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1172/JCI158788x freey FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/d5f3a83a-3afc-47a9-afad-50412b1ec4ec |
856 | 4 8 | u https://doi.org/10.1172/JCI158788 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.